\begin{table}[htbp]\centering\begin{tabular}{lccc}\hline
Characteristic & Good Outcome & Poor Outcome & P-value \\
\hline
Number of patients & 1200 & 746 & \\

\makecell[l]{Outcome} & $14.69 \pm 22.62$ & $631.42 \pm 448.34$ & 0.000 $\uparrow$ \\

\makecell[l]{Gender} & 0: 83.7\%, 1: 16.3\% & 0: 77.3\%, 1: 22.7\% & 0.001  \\

\makecell[l]{First Visit Age} & $22.54 \pm 21.64$ & $22.26 \pm 23.12$ & 0.793  \\

\makecell[l]{CI nd U} & 0: 99.2\%, 1: 0.8\% & 0: 98.5\%, 1: 1.5\% & 0.190  \\

\makecell[l]{Lymphocytes Percentage \\ preclinical} & $38.05 \pm 14.64$ & $40.34 \pm 15.16$ & 0.001 $\uparrow$ \\

\makecell[l]{Lymphocytes Percentage \\ acute} & $32.43 \pm 14.10$ & $34.65 \pm 13.91$ & 0.001 $\uparrow$ \\

\makecell[l]{Lymphocytes Percentage \\ chronic} & $35.43 \pm 9.37$ & $36.50 \pm 11.95$ & 0.027  \\

\makecell[l]{Neutrophils Percentage \\ acute} & $59.37 \pm 15.62$ & $56.92 \pm 14.85$ & 0.001 $\downarrow$ \\

\makecell[l]{Neutrophils Percentage \\ preclinical} & $51.15 \pm 16.08$ & $48.94 \pm 16.49$ & 0.003 $\downarrow$ \\

\makecell[l]{Neutrophils Percentage \\ chronic} & $54.25 \pm 10.27$ & $53.71 \pm 12.76$ & 0.304  \\

\makecell[l]{Monocytes Percentage \\ chronic} & $6.53 \pm 0.77$ & $6.53 \pm 1.22$ & 0.968  \\

\makecell[l]{Monocytes Percentage \\ preclinical} & $6.65 \pm 1.02$ & $6.70 \pm 0.82$ & 0.275  \\

\makecell[l]{Monocytes Percentage \\ acute} & $6.23 \pm 1.09$ & $6.23 \pm 1.04$ & 0.992  \\

\makecell[l]{Mean Corpuscular \\ Hemoglobin \\ Concentration \\ preclinical} & $343.23 \pm 7.04$ & $343.88 \pm 7.38$ & 0.052  \\

\makecell[l]{Mean Corpuscular \\ Hemoglobin \\ Concentration acute} & $336.53 \pm 11.91$ & $338.59 \pm 12.85$ & 0.000 $\uparrow$ \\

\makecell[l]{Mean Corpuscular \\ Hemoglobin \\ Concentration chronic} & $333.81 \pm 4.61$ & $334.04 \pm 8.74$ & 0.442  \\

\makecell[l]{Platelet Count acute} & $260.20 \pm 68.67$ & $258.81 \pm 62.12$ & 0.652  \\

\makecell[l]{Platelet Count \\ preclinical} & $251.41 \pm 52.19$ & $255.30 \pm 50.00$ & 0.104  \\

\makecell[l]{Platelet Count chronic} & $253.78 \pm 31.51$ & $257.54 \pm 57.28$ & 0.062  \\

\makecell[l]{White Blood Cell Count \\ chronic} & $8.44 \pm 1.00$ & $8.67 \pm 2.31$ & 0.003 $\uparrow$ \\

\makecell[l]{White Blood Cell Count \\ preclinical} & $8.59 \pm 1.91$ & $8.52 \pm 1.81$ & 0.447  \\

\makecell[l]{White Blood Cell Count \\ acute} & $9.99 \pm 3.06$ & $9.56 \pm 2.56$ & 0.001 $\downarrow$ \\

\makecell[l]{Mean Corpuscular \\ Hemoglobin acute} & $28.57 \pm 2.02$ & $28.64 \pm 2.04$ & 0.462  \\

\makecell[l]{Mean Corpuscular \\ Hemoglobin preclinical} & $28.45 \pm 1.65$ & $28.30 \pm 1.73$ & 0.055  \\

\makecell[l]{Mean Corpuscular \\ Hemoglobin chronic} & $28.92 \pm 1.42$ & $28.79 \pm 1.75$ & 0.085  \\

\makecell[l]{Mean Corpuscular Volume \\ preclinical} & $83.06 \pm 5.46$ & $82.44 \pm 5.83$ & 0.017  \\

\makecell[l]{Mean Corpuscular Volume \\ chronic} & $86.60 \pm 4.35$ & $86.02 \pm 5.27$ & 0.009 $\downarrow$ \\

\makecell[l]{Mean Corpuscular Volume \\ acute} & $84.90 \pm 6.24$ & $84.57 \pm 5.81$ & 0.236  \\

\makecell[l]{Hemoglobin chronic} & $130.21 \pm 4.80$ & $129.84 \pm 7.44$ & 0.178  \\

\makecell[l]{Hemoglobin acute} & $128.85 \pm 9.78$ & $129.41 \pm 7.91$ & 0.187  \\

\makecell[l]{Hemoglobin preclinical} & $128.09 \pm 7.01$ & $127.20 \pm 8.29$ & 0.011  \\

\makecell[l]{Eosinophils Percentage \\ acute} & $1.73 \pm 2.28$ & $1.60 \pm 1.71$ & 0.164  \\

\makecell[l]{Eosinophils Percentage \\ preclinical} & $2.79 \pm 2.61$ & $2.74 \pm 2.41$ & 0.676  \\

\makecell[l]{Eosinophils Percentage \\ chronic} & $2.32 \pm 1.35$ & $2.29 \pm 1.87$ & 0.712  \\

\makecell[l]{Basophils Percentage \\ preclinical} & $0.27 \pm 0.13$ & $0.27 \pm 0.14$ & 0.717  \\

\makecell[l]{Basophils Percentage \\ acute} & $0.22 \pm 0.19$ & $0.22 \pm 0.17$ & 0.893  \\

\makecell[l]{Basophils Percentage \\ chronic} & $0.30 \pm 0.14$ & $0.30 \pm 0.21$ & 0.987  \\

\makecell[l]{Absolute Eosinophil \\ Count preclinical} & $0.22 \pm 0.33$ & $0.23 \pm 0.31$ & 0.879  \\

\makecell[l]{Absolute Eosinophil \\ Count acute} & $0.15 \pm 0.24$ & $0.14 \pm 0.16$ & 0.160  \\

\makecell[l]{Absolute Eosinophil \\ Count chronic} & $0.18 \pm 0.12$ & $0.18 \pm 0.16$ & 0.910  \\

\makecell[l]{Absolute Lymphocyte \\ Count chronic} & $2.68 \pm 0.85$ & $2.85 \pm 1.10$ & 0.000 $\uparrow$ \\

\makecell[l]{Absolute Lymphocyte \\ Count acute} & $2.96 \pm 1.31$ & $3.03 \pm 1.29$ & 0.269  \\

\makecell[l]{Absolute Lymphocyte \\ Count preclinical} & $3.14 \pm 1.28$ & $3.35 \pm 1.44$ & 0.001 $\uparrow$ \\

\makecell[l]{Mean Platelet Volume \\ acute} & $9.84 \pm 1.16$ & $9.60 \pm 1.10$ & 0.000 $\downarrow$ \\

\makecell[l]{Mean Platelet Volume \\ preclinical} & $9.55 \pm 0.84$ & $9.51 \pm 0.79$ & 0.328  \\

\makecell[l]{Mean Platelet Volume \\ chronic} & $9.11 \pm 0.87$ & $9.21 \pm 1.21$ & 0.042  \\

\makecell[l]{Platelet Distribution \\ Width acute} & $12.04 \pm 2.06$ & $11.85 \pm 1.79$ & 0.034  \\

\makecell[l]{Platelet Distribution \\ Width chronic} & $12.04 \pm 1.16$ & $12.05 \pm 1.74$ & 0.855  \\

\makecell[l]{Platelet Distribution \\ Width preclinical} & $11.86 \pm 1.46$ & $11.75 \pm 1.60$ & 0.124  \\

\makecell[l]{Eosinophil Count \\ Absolute acute} & $128.37 \pm 129.51$ & $124.36 \pm 126.04$ & 0.502  \\

\makecell[l]{Eosinophil Count \\ Absolute chronic} & $179.06 \pm 89.80$ & $183.78 \pm 140.98$ & 0.368  \\

\makecell[l]{Eosinophil Count \\ Absolute preclinical} & $230.82 \pm 183.40$ & $246.76 \pm 272.94$ & 0.124  \\

\makecell[l]{CR eactive Protein \\ chronic} & $5.37 \pm 4.82$ & $6.47 \pm 8.81$ & 0.000 $\uparrow$ \\

\makecell[l]{CR eactive Protein \\ preclinical} & $8.95 \pm 7.76$ & $8.81 \pm 7.16$ & 0.704  \\

\makecell[l]{CR eactive Protein \\ acute} & $10.24 \pm 11.41$ & $8.95 \pm 8.22$ & 0.007 $\downarrow$ \\

\makecell[l]{Immunoglobulin E acute} & $149.02 \pm 107.38$ & $166.20 \pm 113.25$ & 0.001 $\uparrow$ \\

\makecell[l]{Immunoglobulin E \\ chronic} & $220.22 \pm 163.73$ & $219.37 \pm 444.66$ & 0.952  \\

\makecell[l]{Free Thyroxine chronic} & $16.16 \pm 0.83$ & $16.21 \pm 1.04$ & 0.207  \\

\makecell[l]{Free Thyroxine acute} & $15.39 \pm 0.76$ & $15.31 \pm 0.79$ & 0.020  \\

\makecell[l]{SMRNP chronic} & $1.24 \pm 1.70$ & $1.24 \pm 0.68$ & 0.990  \\

\makecell[l]{SMRNP acute} & $1.32 \pm 0.70$ & $1.38 \pm 0.59$ & 0.058  \\

\makecell[l]{Anti SSA chronic} & $1.29 \pm 2.79$ & $1.40 \pm 2.79$ & 0.394  \\

\makecell[l]{Anti SSA acute} & $1.11 \pm 2.90$ & $1.26 \pm 4.29$ & 0.359  \\

\makecell[l]{Anti Jo 1 chronic} & $1.07 \pm 0.99$ & $1.06 \pm 0.45$ & 0.899  \\

\makecell[l]{Anti Jo 1 acute} & $0.81 \pm 0.44$ & $0.84 \pm 0.43$ & 0.274  \\

\makecell[l]{Nucleosome chronic} & $0.53 \pm 0.43$ & $0.54 \pm 0.46$ & 0.526  \\

\makecell[l]{Nucleosome acute} & $1.15 \pm 0.76$ & $1.12 \pm 0.72$ & 0.304  \\

\makecell[l]{Ribosomal PP rotein \\ chronic} & $1.15 \pm 0.23$ & $1.30 \pm 3.20$ & 0.117  \\

\makecell[l]{Ribosomal PP rotein \\ acute} & $1.08 \pm 0.27$ & $1.10 \pm 0.29$ & 0.174  \\

\makecell[l]{Ro 52 chronic} & $1.79 \pm 1.92$ & $1.92 \pm 3.52$ & 0.294  \\

\makecell[l]{Ro 52 acute} & $1.80 \pm 2.05$ & $1.91 \pm 4.32$ & 0.439  \\
\hline\end{tabular}\caption{Comparison of the characteristics between patients with good and poor outcomes in the time dependent dataset \\ continuous variables are presented as mean Â± standard deviation, categorical variables are presented as number (percentage) \\ good outcome is defined as visit duration < 100 days, poor outcome is defined as visit duration $\geq$ 100 days} \label{tab:good_outcome_poor_outcome_time}
\end{table}